AzTrials
AzTrials

Knee ArthritisNCT02740738

Preoperative Pain Threshold and Rapid Recover Programs

A study testing Wagner Pain Algometer and Dynamometer in people with Knee Arthritis and Hip Arthritis, run by Duke University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To investigate the association between grip strength and preoperative pain threshold as measured by pressure algometer and validated pain outcome surveys. Read more about this study

Who is it for?
Ages 18 to 90 years
Conditions the study is for
Knee Arthritis, Hip Arthritis
What is being tested?
Wagner Pain Algometer and Dynamometer
Type of treatment
Medical device
How many people
201 participants
Where
1 siteUnited States
Study dates
Mar 2016to 6 Aug 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • any participant undergoing elective primary total knee arthroplasty or total hip arthroplasty
  • Participants of the following investigators will be approached: Bolognesi, Wellman, Attarian, and Seyler

Who cannot join

  • previous hip or knee surgery in the operative joint

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Duke Medical Plaza Page Road

    Durham, North Carolina, 27703

Other trials in United States

About this study

Official title: Preoperative Pain Threshold and Rapid Recover Programs in Total Joint Arthroplasty

To investigate the association between grip strength and preoperative pain threshold as measured by pressure algometer and validated pain outcome surveys.

Read the detailed description

A minimum of 200 patients, 100 hip and 100 knee arthroplasty participants, will be recruited for this study. Preoperatively, patient pain threshold will be recorded both objectively (Pressure algometer) and subjectively (brief pain inventory). In terms of location, objectively this will be tested during the preoperative visit in clinic by the approved, trained research staff, as well as the subjective brief pain inventory.

Objective pain measure: Pressure algometer will be obtained in the standard fashion as follows: the probe is applied at a 90 degree angle to the skin at a constant rate of 10kPa/s to minimize the impact of the examiner's reaction time on recorded pain thresholds. The participant is instructed by the measurer to say "stop" when the sensation of pressure became the very first sensation of pain. There will be three spots to test patients, one for familiarity of the testing and the other 2 for data collection.

  1. This is initially performed once on ipsilateral the tibialis anterior as a "warm up."
  2. Then 3 measurements are taken on the operative medial epicondyle (for TKA) or ipsilateral lateral iliac crest (for THA) and averaged for the official score.
  3. Lastly, three measurements are also taken on the contralateral olecranon to measure systemic pain sensitivity. If the contralateral elbow has had prior surgery or active bursitis, the ipsilateral elbow will be used. Of important note, the algometer has a max force lock out of 100N to prevent any harm to the patient.
  4. Dominant Hand Grip strength measured by the average of 3 attempts on a Dynamometer.

Subjectively, the brief pain inventory is a validated pain outcome measure which will be filled out by the participant during their preoperative clinic visit.

Postoperative, the study team will ask the participant at the 6 week mark:

  1. How many and what kind of opiates did the participant require?
  2. How many days did the participant require opiates?
  3. Did the participant require a refill? a. If so, did the participant have this filled in clinic preemptively or place a phone call to the office?
Being tested
Wagner Pain Algometer, Dynamometer
Keywords
Knee Arthroplasty, Hip Arthroplasty

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Wagner Pain AlgometerDevice

    applied at a 90 degree angle to the skin at a constant rate of 10kPa/s to minimize the impact of the examiner's reaction time on recorded pain thresholds

  • DynamometerDevice

    Dominant Hand Grip strength measured by the average of 3 attempts

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Inpatient length of stay in days

    amount of time in hospital

    Measured: 1-3 on days average

  2. pain control average visual analogue scale 1 - 10 of hospital stay

    averaging the subjective pain control

    Measured: 1-3 days on average

  3. physical therapy performance on the first day after surgery

    distance walked in feet on post op day 1

    Measured: post op day 1

  4. discharge location placement

    home, rehab or nursing facility

    Measured: 1 - 3 days on average

Secondary outcomes (3)
  1. Outpatient narcotic pill consumption

    narcotic equivalents consumed by patient in morphine equivalents. we will convert all medicine to the standard unit

    Measured: 6-week from surgery

  2. Outpatient narcotic consumption refill needed

    need for refill prescription, yes or no

    Measured: 6-week from surgery

  3. Outpatient narcotic consumption multiple refills needed

    number of refills needed requiring provider time outside of scheduled appointment

    Measured: 6-week from surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Apr 2016 (estimated)
  2. Study startMar 2016
  3. Primary completion30 Jun 2018
  4. Study completion6 Aug 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
201 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02740738
Sponsor's protocol ID
Pro00069521
Status last verified
Apr 2019
First submitted
16 Mar 2016
Last updated
8 Apr 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Wagner Pain Algometer and Dynamometer in people with Knee Arthritis and Hip Arthritis, run by Duke University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Apr 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Inpatient length of stay in days (time frame: 1-3 on days average). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Apr 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in